NEW YORK, NY / ACCESSWIRE / November 16, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Student Transportation Inc (NASDAQ: STB),Medical Marijuana Inc (OTC: MJNA), NanoTech Entertainment Inc (OTC: NTEK) and Pharmacyte Biotech Inc (OTC: PMCB). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
STB Research Package: http://www.traders-choice.com/pdf?s=STB
MJNA Research Package: http://www.traders-choice.com/pdf?s=MJNA
NTEK Research Package: http://www.traders-choice.com/pdf?s=NTEK
PMCB Research Package: http://www.traders-choice.com/pdf?s=PMCB
============
Highlights from today's reports include:
On Friday, November 13, 2015, Nasdaq Composite ended at 4,927.88, down 1.54%, Dow Jones Industrial Average declined 1.16% to finish the day at 17,245.24, and S&P 500 closed at 2,023.04, down 1.12%.
- Student Transportation Inc's stock advanced 0.73% to close Friday's session at USD 4.12. The share price vacillated between USD 4.04 and USD 4.16. The stock recorded a trading volume of 0.19 million shares, which was above its 50-day daily average volume of 0.18 million shares and above its 52-week average volume of 0.14 million shares. Over the last one week Student Transportation Inc's shares have moved up 0.49%. However, in the last six months, the stock has lost 15.87% and year to date, the shares have shed 27.91%. Student Transportation Inc has a current dividend yield of 10.69%. Further, the company is trading at a price to earnings ratio of 137.33 and a price to book ratio of 2.20. This compares to a historical PE ratio of 49.22 and historical PB ratio of 2.22. Additionally, the stock is trading at a price to cash flow ratio of 7.76 and price to sales ratio of 0.77.
- Medical Marijuana Inc's stock edged lower by 3.37% to close Friday's session at USD 0.0430. The company's shares oscillated between USD 0.0350 and USD 0.0480. The stock recorded a trading volume of 1.98 million shares, which was below its 50-day daily average volume of 6.72 million shares and below its 52-week average volume of 4.95 million shares. The stock is currently trading above its 50-day moving average. Over the last three days, Medical Marijuana Inc's shares have declined by 4.44% and in the past one week it has moved up 2.38%. Furthermore, over the last three months, the stock has lost 12.07%. On a compounded total return basis, the company has returned 41.91% in the past one month. The company has a Market Capitalization of USD 79.66 million and Enterprise Value of USD 76.32 million with an Enterprise Value to Revenue ratio of 5.26. Additionally, company has a price to sales ratio of 5.46 and price to book ratio of 0.58.
- The stock of NanoTech Entertainment Inc gained 5.00% to close Friday's session at USD 0.0003. The shares of the company moved in the range of USD 0.0069 and USD 0.0078. A trading volume of 11.69 million shares was recorded, which was greater than its 150-day daily average volume of 10.98 million shares and above its 52-week average volume of 8.62 million shares. Over the last five days, NanoTech Entertainment Inc's shares have advanced 2.08% and in the past one month, it has lost 18.33%. The stock yielded a negative return of 23.44% in the past one month and a negative return of 32.88% in the last three months, on a compounded total return basis. NanoTech Entertainment Inc has a current dividend yield of 13.06%. The stock is at a price to book ratio of 14.58. The historical PB ratio is near to 114.50. Further, the stock is trading at a price to cash flow ratio of 287.98 and price to sales ratio of 1.33.
- Pharmacyte Biotech Inc's stock decreased by 2.00% to close Friday's session at USD 0.0980. The company's shares fluctuated in the range of USD 0.0960 and USD 0.1020. A total of 1.35 million shares exchanged hands, which was lesser than its 50-day daily average volume of 1.80 million shares and was below its 52-week average volume of 2.37 million shares. Over the last three days Pharmacyte Biotech Inc's shares have declined by 4.39% and in the past one week it has moved down 2.78%. Furthermore, over the last three months, the stock has lost 1.90% and in the past six months, the shares have shed 36.16%. The company has a market capitalization of USD 72.86 million and an enterprise value of USD 71.43 million. Additionally, the company has a price to book ratio of 11.11. Further, the stock has a Relative Strength Index (RSI) of 52.58.
--
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice
